Coadministration of Ezetimibe With Fenofibrate Versus Pravastatin Monotherapy for the Treatment of Hyperlipidaemia in HIV-infected Patients

Inclusion Criteria: * patients older than 18 years * documented positive HIV antibodies test * on stable therapy with PIs for at least 12 months * LDL-cholesterol \>130 mg/dl or triglycerides 200 - 500 mg/dl with non-HDL cholesterol \>160 mg/dl * unresponsive to dietary measures and regular physical exercise of at Exclusion Criteria: * history of dyslipidemia before antiretroviral therapy * cardiovascular and cerebrovascular diseases * Cushing's syndrome * concurrent therapy with lipid-lowering agents, oral anticoagulant, estrogens, thiazidic diuretics, beta-blockers * hypothyroidism * Type 1 diabetes mellitus * renal failure